Please login to the form below

Not currently logged in
Email:
Password:

Nycomed reports increased Q1 earnings

Nycomed has posted a 38 per cent increase in pre-tax earnings to €294.4m in the first quarter of 2011, boosted by a one off-payment of €131.1m from its marketing partner Forest Laboratories following the US approval of Daliresp

Nycomed has posted a 38 per cent increase in pre-tax earnings to €294.4m in the first quarter of 2011. This figure was boosted by a one off-payment of €131.1m from its marketing partner Forest Laboratories following the US approval of COPD drug Daliresp (roflumilast).

Its revenues increased by 15 per cent in local currencies, it said, but did not reveal the amount.

The company emphasised progress in the three leading emerging regions, with Russia/CIS registering growth of 34.9 per cent to €139.5m; Latin America growing by almost 25 per cent to €106m; Asia Pacific/Middle East and Africa up by 72 per cent to €91.8m.

Nycomed chief executive Håkan Björklund said: "Continued strong expansion in these younger markets, which we believe will be an engine for growth in our industry, helped to offset declines in Western Europe and the US, with Russia/CIS now our second-largest region after Europe, and Asia Pacific, Middle East overtaking North America in overall sales."

He added: "We believe the anticipated acquisition of Nycomed by Takeda Pharmaceutical Company Limited, announced last week, will bring together Takeda's track record of innovation and Nycomed's efficient commercialisation and manufacturing infrastructure to create a global player able to meet the needs of patients and healthcare providers around the world."

26th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...